Cargando…

Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan

BACKGROUND: Pay-for-Performance programs have shown improvement in indicators monitoring adequacy and target achievement in diabetic care. However, less is known regarding the impact of this program on the occurrence and long-term effects of diabetic retinopathy. The objective of this study was to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheu, Shwu-Jiuan, Lin, Wen-Liang, Kao Yang, Yea-Huei, Hwu, Chi-Min, Cheng, Ching-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094472/
https://www.ncbi.nlm.nih.gov/pubmed/30111370
http://dx.doi.org/10.1186/s12913-018-3454-6
_version_ 1783347823482241024
author Sheu, Shwu-Jiuan
Lin, Wen-Liang
Kao Yang, Yea-Huei
Hwu, Chi-Min
Cheng, Ching-Lan
author_facet Sheu, Shwu-Jiuan
Lin, Wen-Liang
Kao Yang, Yea-Huei
Hwu, Chi-Min
Cheng, Ching-Lan
author_sort Sheu, Shwu-Jiuan
collection PubMed
description BACKGROUND: Pay-for-Performance programs have shown improvement in indicators monitoring adequacy and target achievement in diabetic care. However, less is known regarding the impact of this program on the occurrence and long-term effects of diabetic retinopathy. The objective of this study was to determine the effect of pay-for-performance program on the development of treatment needed for diabetic retinopathy in type 2 diabetes patients. METHODS: We conducted a nationwide retrospective cohort study with a matching design using the Taiwan National Health Insurance Research Database from 2000 to 2012. The outcome was defined as the treatment needed diabetic retinopathy. We matched Pay-for-Performance and non-Pay-for-Performance groups for age, gender, year diabetes was diagnosed and study enrollment, and duration of follow-up. RESULTS: A total of 9311 patients entered the study cohort, of whom 2157 were registered in the Pay-for-Performance group and 7154 matched in the non-Pay-for-Performance group. The incidence of treatment needed diabetic retinopathy was not significantly different in two groups. However, the incidence of treatment needed diabetic retinopathy was significantly different if restricted the non-Pay-for-Performance group who had at least 1 eye examination or optical coherence tomography within 1 year (adjusted hazard ratio, 0.78; 95% confidence interval, 0.64–0.94). CONCLUSIONS: Pay-for-Performance is valuable in preventing the development of treatment needed diabetic retinopathy, which could be attributed to the routine eye examination required in the Pay-for-Performance program. We could improve our diabetic care by promoting eye health education and patient awareness on the importance of regular examinations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-018-3454-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6094472
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60944722018-08-20 Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan Sheu, Shwu-Jiuan Lin, Wen-Liang Kao Yang, Yea-Huei Hwu, Chi-Min Cheng, Ching-Lan BMC Health Serv Res Research Article BACKGROUND: Pay-for-Performance programs have shown improvement in indicators monitoring adequacy and target achievement in diabetic care. However, less is known regarding the impact of this program on the occurrence and long-term effects of diabetic retinopathy. The objective of this study was to determine the effect of pay-for-performance program on the development of treatment needed for diabetic retinopathy in type 2 diabetes patients. METHODS: We conducted a nationwide retrospective cohort study with a matching design using the Taiwan National Health Insurance Research Database from 2000 to 2012. The outcome was defined as the treatment needed diabetic retinopathy. We matched Pay-for-Performance and non-Pay-for-Performance groups for age, gender, year diabetes was diagnosed and study enrollment, and duration of follow-up. RESULTS: A total of 9311 patients entered the study cohort, of whom 2157 were registered in the Pay-for-Performance group and 7154 matched in the non-Pay-for-Performance group. The incidence of treatment needed diabetic retinopathy was not significantly different in two groups. However, the incidence of treatment needed diabetic retinopathy was significantly different if restricted the non-Pay-for-Performance group who had at least 1 eye examination or optical coherence tomography within 1 year (adjusted hazard ratio, 0.78; 95% confidence interval, 0.64–0.94). CONCLUSIONS: Pay-for-Performance is valuable in preventing the development of treatment needed diabetic retinopathy, which could be attributed to the routine eye examination required in the Pay-for-Performance program. We could improve our diabetic care by promoting eye health education and patient awareness on the importance of regular examinations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-018-3454-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-15 /pmc/articles/PMC6094472/ /pubmed/30111370 http://dx.doi.org/10.1186/s12913-018-3454-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sheu, Shwu-Jiuan
Lin, Wen-Liang
Kao Yang, Yea-Huei
Hwu, Chi-Min
Cheng, Ching-Lan
Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan
title Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan
title_full Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan
title_fullStr Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan
title_full_unstemmed Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan
title_short Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan
title_sort pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in taiwan
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094472/
https://www.ncbi.nlm.nih.gov/pubmed/30111370
http://dx.doi.org/10.1186/s12913-018-3454-6
work_keys_str_mv AT sheushwujiuan payforperformanceprogramreducestreatmentneededdiabeticretinopathyanationwidematchedcohortstudyintaiwan
AT linwenliang payforperformanceprogramreducestreatmentneededdiabeticretinopathyanationwidematchedcohortstudyintaiwan
AT kaoyangyeahuei payforperformanceprogramreducestreatmentneededdiabeticretinopathyanationwidematchedcohortstudyintaiwan
AT hwuchimin payforperformanceprogramreducestreatmentneededdiabeticretinopathyanationwidematchedcohortstudyintaiwan
AT chengchinglan payforperformanceprogramreducestreatmentneededdiabeticretinopathyanationwidematchedcohortstudyintaiwan